Education:
-
Ph.D. 2024 (Expected)Supply Chain and Operations, Carlson School of Management, University of Minnesota - Twin Cities
-
Post-Graduate Programme in Management 2013Management, Indian School of Business, Hyderabad (India)
-
Bachelor of Technology 2008Mechanical Engineering, National Institute of Technology, Warangal (India)
Expertise:
-
Empirical Pharmaceutical Operations
-
Innovation & New product development
-
Shortages and stockouts
-
Supply chain transparency
Biography
I am a fifth-year Ph.D. candidate in the Supply Chain and Operations department at the Carlson School of Management, University of Minnesota. I study tensions between operational outcomes in pharmaceutical supply chains such as novelty, quality and safety, availability, and equity and inclusion. In my dissertation, I examine how transparency inhibits drug novelty (essay 1), expedited approvals impact drug safety (essay 2), and quality failures impact drug availability (essay 3). I compile unique datasets and use empirical research methods to generate insights for operations management theory, practice, and policymakers in the pharmaceutical industry.
Before joining the Ph.D. program, I worked as a Research Associate at the Indian School of Business, Hyderabad (India). Before entering academia, I worked as a management consultant at EY-Parthenon (Dubai, UAE) and ZS Associates (Pune, India). I also worked in the management trainee program at Ranbaxy Labs. Ltd (Gurgaon, India). I have a Post-Graduate Programme in Management from the Indian School of Business, Hyderabad (India), and a Bachelor of Technology from the National Institute of Technology, Warangal (India).
On the personal front, I am a traveler, a hiking/trekking enthusiast, and an open-water scuba diver. I am also an avid music lover who is learning Hindustani classical singing.
Selected Works & Activities
-
Journal ArticlesDeo, S., H. Tyagi, C. Chatterjee, H. Molakapuri. 2019. Did India's price control policy for coronary stents create unintended consequences? Social Science & Medicine 246, 112737
-
Journal ArticlesH. Tyagi, M. Sabharwal, N. Dixit, A. Pal, S. Deo. 2020. Leveraging providers' preferences to customize instructional content: A retrospective analysis of a mobile phone-based intervention. JMIR mHealth and uHealth 8 (3), e15998
-
Conference ProceedingsTyagi, H., Hermosilla, M., & Shah, R. (2023). How does Transparency Impact Technological Novelty? Evidence from Large Pharmaceutical Firms. In Academy of Management Proceedings (Vol. 2023, No. 1, p. 13909). Briarcliff Manor, NY: Academy of Management
-
Conference ProceedingsV Heitlage, JF Farley, R Shah, H Tyagi, D Stenehjem. 2022. EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health 25 (7), S460